Nicox Ophthalmics, Inc.
7 clinical trials · Sponsor
◉ Watch Nicox Ophthalmics, Inc.
| Record | Firm | Date |
|---|---|---|
| Aqueous Humor Dynamics of NCX 470 Ophthalmic Solution (NCT05938699) | Nicox Ophthalmics, Inc. | 2023-12-12 |
| Study Evaluating the Safety and Efficacy of NCX 4251 Ophthalmic Suspension for the Treatment of Blepharitis (NCT04675242) | Nicox Ophthalmics, Inc. | 2020-12-14 |
| MRCT Evaluating NCX 470 vs. Latanoprost in Subjects With Open-Angle Glaucoma or Ocular Hypertension (NCT04630808) | Nicox Ophthalmics, Inc. | 2020-11-09 |
| Phase 3 Trial of NCX 470 vs. Latanoprost in Subjects With Open-Angle Glaucoma or Ocular Hypertension (NCT04445519) | Nicox Ophthalmics, Inc. | 2020-06-01 |
| Study Evaluating the Safety and Tolerability of NCX 4251 for the Treatment of Acute Exacerbations of Blepharitis (NCT03926026) | Nicox Ophthalmics, Inc. | 2019-03-18 |
| Phase 2 Dose-Response Study Evaluating the Safety and Efficacy of NCX 470 vs Latanoprost in Subjects With Open-Angle Glaucoma or Ocular Hypertension (NCT03657797) | Nicox Ophthalmics, Inc. | 2018-08-01 |
Track Nicox Ophthalmics, Inc. automatically
Every clearance here is in the API, with alerts when new ones post.